Literature DB >> 18431160

Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.

Veli Berk1, Ramazan Yildiz, Umit Ozgur Akdemir, Nalan Akyurek, Nese Ilgin Karabacak, Ugur Coskun, Mustafa Benekli.   

Abstract

A 49-year-old man presented with a left nasal cavity mass, biopsy of which revealed extranodal NK/T cell lymphoma. A PET-CT scan showed increased F-18 FDG uptake in the nasal mass, anterior mediastinal lymph nodes, and multiple subcutaneous nodular deposits in the chest wall, gluteal region, and right femoral areas. The patient achieved complete remission with salvage l-asparaginase therapy after failing first-line standard anthracycline-based chemotherapy. PET-CT was very useful in detecting subcutaneous nodules consistent with widespread dissemination. There is limited literature data on the use of the PET scan in the diagnosis and staging of extranodal nasal NK/T-cell lymphomas. Our case highlights the important role of F-18 FDG PET in the staging of these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431160     DOI: 10.1097/RLU.0b013e31816a7a23

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  PET in T-Cell Lymphoma.

Authors:  Pier Luigi Zinzani
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

Review 2.  Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature.

Authors:  Dong Ming Li; Li De Lun
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

3.  PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: a case series.

Authors:  Shannon L MacDonald; Liam Mulroy; Derek R Wilke; Steven Burrell
Journal:  Radiat Oncol       Date:  2011-12-30       Impact factor: 3.481

4.  Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.

Authors:  S Horwitz; B Coiffier; F Foss; H M Prince; L Sokol; M Greenwood; D Caballero; F Morschhauser; L Pinter-Brown; S P Iyer; A Shustov; J Nichols; J Balser; B Balser; B Pro
Journal:  Ann Oncol       Date:  2015-01-20       Impact factor: 32.976

5.  Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.

Authors:  Ping Dong; Li Wang; Guohua Shen; Lin Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.